CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Option exercise See Remarks acquired 60,000 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Chief Medical Officer gave up 16,073 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 11,570 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 14,136 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 16,104 shares (to pay taxes)
- 4 Shares withheld for taxes President, CEO, and Chairman gave up 106,093 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Accounting Officer gave up 12,132 shares (to pay taxes)
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 2 of 16 · 316 filings